| LZISX | TRZKX | LZISX / TRZKX | |
| Total Expense Ratio | 1.03 | 0.00 | - |
| Annual Report Gross Expense Ratio | 2.33 | 1.06 | 220% |
| Fund Existence | 32 years | 5 years | - |
| Gain YTD | 10.009 | 5.996 | 167% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 14.3M | 6.44B | 0% |
| Annual Yield % from dividends | 1.76 | 2.57 | 68% |
| Returns for 1 year | 44.99 | 27.84 | 162% |
| Returns for 3 years | 47.52 | 39.63 | 120% |
| Returns for 5 years | -7.14 | N/A | - |
| Returns for 10 years | 32.85 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MAIMX | 25.07 | 0.15 | +0.60% |
| Victory Integrity Mid-Cap Value A | |||
| FBTDX | 150.09 | 0.64 | +0.43% |
| Franklin Biotechnology Discovery C | |||
| DCDGX | 13.23 | 0.01 | +0.08% |
| Dunham Small Cap Growth C | |||
| PAEAX | 22.06 | -0.09 | -0.41% |
| Putnam Dynamic Asset Allocation Gr A | |||
| MGRVX | 48.96 | -0.31 | -0.63% |
| MFS International Growth R4 | |||